
Tumour Markers Explained: What CEA, CA 19-9, AFP, CA 125 and PSA Mean
Tumour markers are often included in blood test packages, and a result outside the range can be worrying. Most of the time, a raised tumour marker turns out not to be cancer. This guide explains what tumour markers are, what the common markers mean, why they cannot diagnose or rule out cancer on their own, and how to use them sensibly.
Part of our blood test results guide: what each marker means and when it is worth testing. New to testing? Start with our guide to getting a blood test in KL.
Key takeaways
- Tumour markers are substances, usually proteins, found in the blood that can be produced by cancer cells, or by normal cells in response to cancer or certain benign conditions.
- A raised tumour marker is not a diagnosis. Infection, inflammation, liver disease, smoking and other non-cancer conditions can all raise markers.
- A normal result does not rule cancer out. Not every cancer produces a marker, and early cancers often do not.
- Tumour markers are most useful for monitoring a known cancer and as a prompt for further checks . Only a few tumour markers are used to look for cancer in people without symptoms.
- The trend matters more than a single number. A marker that keeps rising deserves follow-up; a one-off mild rise often settles.
What are tumour markers?
Tumour markers (spelt tumor markers in US English, and also called cancer markers) are substances found in the blood, urine or tumour tissue. Many are proteins; some are hormones, enzymes or genetic changes in tumour cells. Some are made in higher amounts by cancer cells than by normal cells. Others are made by the body in response to cancer, or in response to certain benign conditions, such as inflammation.
A tumour marker test measures the level of one of these substances. Some tumour markers are linked mainly to one type of cancer; others can be raised in certain types of cancer such as lung cancer or bladder cancer, and in conditions that are not cancer at all. A high level does not by itself confirm the presence of cancer. That overlap is the reason tumour markers need careful interpretation.
What are tumour markers used for?
- Monitoring treatment. In people already diagnosed with cancer, a falling tumour marker can show the treatment is working. This is the most important use of most tumour markers.
- Checking for recurrence. After treatment, a rising tumour marker can be an early sign that the cancer has come back, prompting imaging tests.
- Supporting a diagnosis. Together with symptoms, imaging tests and a biopsy, a tumour marker can help doctors decide on the type of cancer and plan cancer care. A biopsy, not a blood test, confirms a cancer diagnosis.
- Checking people at higher risk. Only a few tumour markers are used this way. For example, AFP is used with liver ultrasound to watch people with chronic hepatitis B or cirrhosis, and PSA testing is an individual decision for men.
Tumour markers cannot diagnose cancer on their own, and a single tumour marker test is not a reliable way to find cancer in its early stages in people without symptoms.
Common tumour markers and what they mean
These are the tumour marker tests in common use. Ranges vary by laboratory, so read your result against the range on your own report.
| Tumour marker | Linked mainly to | Can also be raised by |
|---|---|---|
| CEA (carcinoembryonic antigen) | Colorectal cancer; also some other gastrointestinal, lung and breast cancers | Smoking, inflammatory bowel disease, pancreatitis, liver disease |
| CA 19-9 | Pancreatic and bile duct cancer | Pancreatitis, a blocked bile duct, gallstones, liver disease |
| AFP (alpha-fetoprotein) | Liver cancer and some germ cell tumours | Hepatitis, cirrhosis, pregnancy |
| CA 125 | Ovarian cancer | Periods, endometriosis, fibroids, pelvic infection, pregnancy, liver disease |
| CA 15-3 | Breast cancer (mainly for monitoring) | Benign breast and liver conditions |
| PSA (prostate-specific antigen) | Prostate cancer | An enlarged prostate, prostatitis, urinary infection, recent ejaculation or cycling |
| CA 72-4 | Stomach cancer | Some benign stomach and digestive conditions |
| EBV antibody (EBVA) | Nasopharyngeal cancer, more common in people of southern Chinese descent | Past Epstein–Barr virus infection, which is very common |
This list is not complete: many different tumour markers exist, including markers used only for specific cancers such as thyroid cancer, germ cell tumours and gastrointestinal stromal tumours.
Why a raised tumour marker does not mean cancer
Most tumour markers are made in small amounts by normal cells too. Many benign conditions raise tumour marker levels: for example, CA 125 can rise during a period or with endometriosis, CEA is often higher in smokers, and CA 19-9 rises when the bile duct is blocked by a gallstone. A mildly raised tumour marker in someone without symptoms is far more often due to one of these causes than to cancer.
The opposite is also true. Not all cancers make a tumour marker, and an early, small cancer may not raise it enough to show. So a normal tumour marker result is reassuring for that marker, but it does not rule cancer out. If you have symptoms, see a doctor even if your markers are normal.
What to do if your tumour marker is high
- Do not panic. Look at how far above the range the tumour marker is, and whether there is an obvious benign cause, such as a recent infection, a period, smoking or known liver disease.
- Repeat the test. Your doctor may repeat it after a few weeks. A tumour marker level that is stable or falling is less concerning than one that keeps rising.
- Look at the full picture. Liver and kidney function, inflammation, symptoms and family history all help explain a raised tumour marker.
- See a doctor for assessment. If a tumour marker stays high or keeps rising, a doctor may arrange imaging tests, such as an ultrasound or scan, or refer you to a specialist.
We explain what your tumour marker results may mean, what else could cause them, and when to see a doctor. We do not diagnose cancer.
Tumour markers vs cancer screening
Tumour markers are not a substitute for proven tests. In Malaysia, the main evidence-based ways to find cancer early are a stool test (FIT) or colonoscopy for colorectal cancer, a Pap smear or HPV test for cervical cancer, and a mammogram for breast cancer. These are done separately from our blood tests; a doctor or government clinic can arrange them.
A sensible approach is to use those proven tests for the cancers they cover, and to read tumour markers as one extra piece of information, especially if you have a family history or are being monitored after cancer treatment.
How to prepare for a tumour marker test
- No fasting is needed for tumour markers. If your package includes fasting glucose or a lipid profile, fast for 8–12 hours; plain water is fine.
- PSA: avoid ejaculation and long-distance cycling for about two days before the test, as both can raise PSA temporarily.
- CA 125: your result may be higher during a period, so tell us where you are in your cycle.
- Recent illness: tell us about any recent infection, pancreatitis or jaundice, which can raise some markers.
Tumour marker tests at HDC Medical
Our VIP Cancer Monitoring package is designed to track tumour markers over time, alongside organ function and inflammation. It includes CEA, CA 19-9, AFP and CA 72-4, plus CA 125 and CA 15-3 for women and PSA for men, from RM599. Our Gold, Platinum and Diamond blood test packages also include core cancer markers. Prices may change; please confirm when you book.
Every package includes a one-to-one review of your results. Tumour markers are used for monitoring and as a prompt for further checks. A raised result is not a diagnosis, and a normal result does not rule cancer out. We explain what yours mean, and when to see a doctor.
Related reading: cancer marker test in KL , pancreatic cancer blood test (CA 19-9) , ovarian cancer blood test (CA 125) .
References
- National Cancer Institute (US). Tumor markers. Updated regularly.
- Ministry of Health Malaysia. National Strategic Plan for Cancer Control Programme 2021–2025.
- US Preventive Services Task Force. Ovarian cancer screening (2018) and prostate cancer screening (2018) recommendations.
This article is for general education and does not replace personalised medical advice. Reference ranges vary between laboratories — always interpret your results with a qualified professional. HDC Medical is a dietitian-led health screening centre in Oval Damansara, Kuala Lumpur.
Frequently asked questions
Do tumour markers mean cancer?
No. Tumour markers can be raised by many benign conditions, such as infection, inflammation, liver disease, smoking or, for CA 125, a period. A raised marker is a prompt for further checks, not a diagnosis.
Can tumour markers detect cancer early?
Not reliably. Many early cancers do not raise tumour markers, so a normal result does not rule cancer out. Proven tests, such as a stool test, Pap smear and mammogram, are better for finding cancer early.
What if my tumour markers are high?
Look for benign causes, and repeat the test. A doctor may arrange imaging if the level stays high or keeps rising. A single mildly raised result is usually not cancer.
What is a normal CEA level?
Many laboratories use an upper limit of around 3–5 µg/L, and smokers often have slightly higher levels. Always check the range on your own report.
Is CA 125 a good test for finding ovarian cancer?
Not on its own for women at average risk, because it is often raised by benign conditions and can be normal in early ovarian cancer. It is most useful for monitoring, or with an ultrasound in women at higher risk.
Do I need to fast for a tumour marker test?
No. Tumour markers do not need fasting, but fast for 8–12 hours if the same blood draw includes fasting glucose or a lipid profile.
Understand your tumour markers, with someone to explain them.
Book a dietitian-led screening at HDC Medical in Kuala Lumpur. Your results explained in plain language, with a plan to follow.



